Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Technetium Tc 99m Medronate × Clear all

NCT05924672 2026-01-14

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Phase 2 Active not recruiting

Prostatic Neoplasms